Intent to sole source to Fenwal, Inc. for Amicus Apheresis Separator and consumables

Notice of Intent to Sole Source
HT941023N0087
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Markets Contracting Division (WMCD), San Diego, intends to negotiate and award a firm fixed price contract for the Amicus Apheresis Separator and consumables from FENWAL, INC. in accordance with Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to:
FENWAL, INC.
3 CORPORATE DR STE 300
LAKE ZURICH, IL 60047 USA
The North American Industry Classification System (NAICS) code for this requirement is 339112 – Surgical and Medical Instrument Manufacturing; the business size standard is 1,000 employees. The Product Service Code (PSC) is 6515 – Medical and Surgical Instruments, Equipment, and Supplies
The US Naval Hospital Okinawa provide medical readiness for U.S. Pacific Fleet. Having a dedicated contracted support system for US Naval Hospital Okinawa will allow uninterrupted operational support for the waterfront.
The objective of this sole source award is to procure two (2) Amicus Apheresis Separator and consumables (listed below). Fenwal, Inc. doesn’t have distributors for their products and ship directly to consumers.
AMICUS APHERESIS SEPARATOR (6R4590)
Quantity 2
Delivery by 30SEP2023
Consumables:
Item#
Description
CAT#
QTY(KT)
1
Intersol Solution
X6B7850
24 CS
2
Apheresis Kit- Closed Single Needle
4R2337
88 CS
3
Sepacell Leukocyte Filter
4C2300
1 CS
Delivery Schedule
1
Intersol Solution
2-Oct-2023
1-Jan-2024
1-Apr-2024
1-Jul-2024
QTY
6 CS
6 CS
6 CS
6 CS
2
Apheresis Kit- Closed Single Needle
2-Oct-2023
1-Jan-2024
1-Apr-2024
1-Jul-2024
QTY
22 CS
22 CS
22 CS
22 CS
3
Sepacell Leukocyte Filter
1-Jan-2024
QTY
1 CS
The items shall be shipped to:
U.S. SHIPPING ADDRESS:
Cardinal Health MPS Distribution Center
4551 East Philadelphia Street
Ontario, CA 91761
SHIP TO ADDRESS OKINAWA JAPAN:
US Naval Hospital Okinawa/PACOM ASBBC
Camp Foster BLDG 966
Tarawa Road, Ginowan-shi
Okinawa Japan 901-2221
Based on market research, FENWAL, INC., is the only source that can meet the Government’s minimum requirements for the Amicus Apheresis Separator and consumables from FENWAL, INC. at US Naval Hospital Okinawa
This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required services for US Naval Hospital Okinawa. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.
If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Renier Valdez at renier.s.valdez.civ@health.mil. The closing date for challenges is no later than 11:00 Pacific Time, 18 August 2023.
NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED. Cassi Jo Newman
Contracting Officer
8/3/23 NEWMAN.CASSI.JO.1
239326257
Digitally signed by
NEWMAN.CASSI.JO.123932625
7